Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Manu Sharma

Showing results (311-320 of 325) with videos related to

Pageof 33
Sort By:
Neurobiology of Aging|August 22, 2013
Protective effect of LRRK2 p.R1398H on risk of Parkinson's disease is independent of MAPT and SNCA variantsMichael G Heckman, Alexis Elbaz, Alexandra I Soto-Ortolaza, et al.
The Lancet. Neurology|September 3, 2011
Association of LRRK2 exonic variants with susceptibility to Parkinson's disease: a case-control studyOwen A Ross, Alexandra I Soto-Ortolaza, Michael G Heckman, et al.
Brain : a Journal of Neurology|November 23, 2019
Genetic modifiers of risk and age at onset in GBA associated Parkinson's disease and Lewy body dementiaCornelis Blauwendraat, Xylena Reed, Lynne Krohn, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|August 6, 2013
Population-specific frequencies for LRRK2 susceptibility variants in the Genetic Epidemiology of Parkinson's Disease (GEO-PD) ConsortiumMichael G Heckman, Alexandra I Soto-Ortolaza, Jan O Aasly, et al.
Journal of Medical Genetics|November 6, 2012
A multi-centre clinico-genetic analysis of the VPS35 gene in Parkinson disease indicates reduced penetrance for disease-associated variantsManu Sharma, John P A Ioannidis, Jan O Aasly, et al.
NPJ Parkinson'S Disease|May 28, 2026
Genetic variation in antidiabetic drug targets: associations with Parkinson's disease risk and age at onsetKatalin Vincze, Agnieszka Szwajda, Alexander Ploner, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|July 10, 2022
The Interaction between HLA-DRB1 and Smoking in Parkinson's Disease RevisitedCloé Domenighetti, Venceslas Douillard, Pierre-Emmanuel Sugier, et al.
Medrxiv : the Preprint Server for Health Sciences|September 4, 2024
Genome-wide association study of copy number variations in Parkinson's diseaseZied Landoulsi, Ashwin Ashok Kumar Sreelatha, Claudia Schulte, et al.
NPJ Parkinson'S Disease|April 20, 2026
Genome-wide association study of copy number variations in Parkinson's diseaseZied Landoulsi, Ashwin Ashok Kumar Sreelatha, Nicole Kuznetsov, et al.
Neurology|July 10, 2024
Association of Body Mass Index and Parkinson Disease: A Bidirectional Mendelian Randomization StudyCloé Domenighetti, Pierre-Emmanuel Sugier, Ashwin Ashok Kumar Sreelatha, et al.
Pageof 33

Showing results (311-320 of 325) with videos related to

Sort By:
Pageof 33
Neurobiology of Aging|August 22, 2013
Protective effect of LRRK2 p.R1398H on risk of Parkinson's disease is independent of MAPT and SNCA variantsMichael G Heckman, Alexis Elbaz, Alexandra I Soto-Ortolaza, et al.
The Lancet. Neurology|September 3, 2011
Association of LRRK2 exonic variants with susceptibility to Parkinson's disease: a case-control studyOwen A Ross, Alexandra I Soto-Ortolaza, Michael G Heckman, et al.
Brain : a Journal of Neurology|November 23, 2019
Genetic modifiers of risk and age at onset in GBA associated Parkinson's disease and Lewy body dementiaCornelis Blauwendraat, Xylena Reed, Lynne Krohn, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|August 6, 2013
Population-specific frequencies for LRRK2 susceptibility variants in the Genetic Epidemiology of Parkinson's Disease (GEO-PD) ConsortiumMichael G Heckman, Alexandra I Soto-Ortolaza, Jan O Aasly, et al.
Journal of Medical Genetics|November 6, 2012
A multi-centre clinico-genetic analysis of the VPS35 gene in Parkinson disease indicates reduced penetrance for disease-associated variantsManu Sharma, John P A Ioannidis, Jan O Aasly, et al.
NPJ Parkinson'S Disease|May 28, 2026
Genetic variation in antidiabetic drug targets: associations with Parkinson's disease risk and age at onsetKatalin Vincze, Agnieszka Szwajda, Alexander Ploner, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|July 10, 2022
The Interaction between HLA-DRB1 and Smoking in Parkinson's Disease RevisitedCloé Domenighetti, Venceslas Douillard, Pierre-Emmanuel Sugier, et al.
Medrxiv : the Preprint Server for Health Sciences|September 4, 2024
Genome-wide association study of copy number variations in Parkinson's diseaseZied Landoulsi, Ashwin Ashok Kumar Sreelatha, Claudia Schulte, et al.
NPJ Parkinson'S Disease|April 20, 2026
Genome-wide association study of copy number variations in Parkinson's diseaseZied Landoulsi, Ashwin Ashok Kumar Sreelatha, Nicole Kuznetsov, et al.
Neurology|July 10, 2024
Association of Body Mass Index and Parkinson Disease: A Bidirectional Mendelian Randomization StudyCloé Domenighetti, Pierre-Emmanuel Sugier, Ashwin Ashok Kumar Sreelatha, et al.
Pageof 33